Teva Pharmaceutical announced the launch of a generic version of Sabril (vigabatrin) tablets, 500 mg in the US, the first generic version of Sabril tablets to enter the US market.....
MSD’s Keytruda (pembrolizumab) made an impact at the European Society for Medical Oncology 2018 Congress as the company unveiled new Phase 3 data into its efficacy in the first-line treatment...